NCT06666101View on ClinicalTrials.gov

Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE)

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

November 4, 2025

Study Completion Date

December 31, 2025

Conditions
Polyvascular Disease
Interventions
DIETARY_SUPPLEMENT

Long chain polyunsaturated Omega-3

2 capsules of fatty acids in the morning and 2 capsules in the evening except the first day, 4 soft gels in a single administration in the morning, ± 2,6 g/d

DIETARY_SUPPLEMENT

Placebo

Olive oil

All Listed Sponsors
collaborator

University of Mons

OTHER

collaborator

Université Catholique de Louvain

OTHER

lead

Université Libre de Bruxelles

OTHER

NCT06666101 - Effects of n3 LC PUFAs on Inflammatory, Immune and Senescence Features in Polyvascular Older Subjects (OMSAGE) | Biotech Hunter | Biotech Hunter